A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects
Status:
COMPLETED
Trial end date:
2024-08-19
Target enrollment:
Participant gender:
Summary
This is a dose escalation trial. The dosing regimen involves a single-dose study. This is a single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetic characteristics of TQC3927 powder for inhalation in healthy adults subjects.